Background The present study evaluated whether the short-and long-term outcomes improved during our 23 years of experience treating 144 consecutive patients with hilar cholangiocarcinoma. Methods Patients treated between 1990 and 2000 (period 1; n = 70) were retrospectively compared with those treated between 2001 and 2012 (period 2; n = 74). Mortality and major complications were defined as any death occurring within 90 days of surgery and a grade III-IV complication according to the Clavien classification, respectively. Results The mortality and major complication rates decreased from 1.2 and 34 % during period 1-0 and 24 % during period 2, respectively. Although the surgical procedure was comparable between the two periods, the median blood loss was significantly reduced from 1,020 mL during period 1-745 mL during period 2 (P = 0.003), and blood loss was the only significant predictor of postoperative morbidity in a multivariable analysis. The R0 resection rate (70 vs. 78 %, P = 0.250) and the 5-year survival rate (33 vs. 35 %, P = 0.529) were similar for the two periods. A multivariable analysis identified positive nodal involvement and R1-2 resection as independent prognostic factors for survival. Conclusions The perioperative outcomes after surgical treatment for hilar cholangiocarcinoma have steadily improved through the accumulation of experience and meticulous surgical techniques to reduce blood loss. Further improvement of the R0 resection rate could prolong patient survival.
Introduction
Surgical resection with negative margins has long been recognized as providing the only chance for a cure and long-term survival in patients with hilar cholangiocarcinoma [1] [2] [3] ; however, the close proximity to hilar structures, such as the hepatic artery and portal vein, and the longitudinal extension of the tumor make curative resection difficult [4, 5] . Moreover, radical surgical treatment often necessitates an extensive hepatic resection concomitantly with a caudate lobectomy [6] [7] [8] [9] , considerably increasing the operative risks, especially in patients with a cholestasisinduced impairment of liver function [7, 10, 11] .
Since 1990, we have routinely adopted an aggressive and uniform surgical approach whenever possible; this approach typically includes a major hepatectomy (three or more Couinaud's segments) with a total caudate lobectomy, extrahepatic bile duct resection, and dissection of the regional lymph nodes in patients with hilar cholangiocarcinoma [9, 12] . As preoperative adjuncts, we have also applied portal vein embolization (PVE) [13] and biliary decompression [14] when indicated. The aim of the present study was to evaluate whether the short-and long-term outcomes after surgical treatment for hilar cholangiocarcinoma have improved during our 23 years of experience performing 144 consecutive resections.
Materials and methods
Between January 1990 and December 2012, a total of 253 patients were diagnosed as having hilar cholangiocarcinoma and were admitted to the First Department of Surgery, Shinshu University Hospital, Japan. Hilar cholangiocarcinoma was defined as a tumor originating in the upper common, right, or left hepatic duct. Among these patients, 144 patients who had undergone surgical resection were retrospectively enrolled in the present study (resectability rate 57 %). The patients were divided into two groups according to the period during which they underwent surgery: 1990-2000 (period 1; n = 70) and 2001-2012 (period 2; n = 74). None of the patients in this series received chemotherapy and/or radiotherapy preoperatively.
Our principle treatment protocol, which was consistent throughout both study periods, is described below [15] .
Preoperative management
The location of the tumor was clarified using ultrasonography (US), computed tomography (CT), and/or magnetic resonance cholangiopancreatography (MRCP). Tumors with para-aortic lymph node involvement or hepatic or distant metastases were considered to be unresectable. The decision regarding whether a right-or left-sided hepatectomy should be performed was made according to the predominant site of the cancer: when the predominant site was the right hepatic duct or when both hepatic ducts were involved equally, a right hemihepatectomy was considered to be indicated, whereas a left hemihepatectomy was selected for patients in whom the left hepatic duct was mainly involved.
For patients with obstructive jaundice, we performed preoperative biliary decompression using either percutaneous transhepatic cholangiodrainage [14] or endoscopic retrograde biliary drainage. Our policy was to perform unilateral biliary decompression of the remnant hemiliver after the resection. Longitudinal tumor extension was assessed using direct opacification of the bile duct during MRCP and/or multidetector-row CT.
If the scheduled liver resection encompassed more than 60 % of the total liver parenchyma, as calculated from serial CT images, preoperative PVE was considered to be indicated to reduce the risk of postoperative liver insufficiency, once the serum total bilirubin level had decreased to \5 mg/dL [13] . The resectional surgery was planned for 2-3 weeks after the PVE, once hypertrophy of the future remnant liver (more than 40 % of the total liver volume) had been confirmed by successive CT scans and the serum total bilirubin level had decreased to \2 mg/dL. Tumor, node, metastasis (pTMN) staging was performed according to the staging manual of the American Joint Committee on Cancer (7th edition) [16] .
Intraoperative management
The standard curative operation consisted of mainly a right or left hepatectomy, resection of the entire caudate lobe and extrahepatic bile duct, and dissection of the lymph nodes and connective tissues in the hepatoduodenal ligament, posterior to the upper portion of the pancreatic head, and around the common hepatic artery. Liver resection was performed using the clamp-crushing method and/or with an ultrasonic dissector under the routine application of the intermittent inflow occlusion technique [17] . A concomitant pancreaticoduodenectomy (PD) was indicated if the tumor's distal border was considered to be in the intrapancreatic bile duct and/or if peripancreatic head lymph node metastasis was suspected. A closed silicone drain was inserted along the cut surface of the liver and behind the bilioenteric anastomosis prior to the closure of the abdominal wound.
Adjuvant chemotherapy
Since 2008, a total of 22 patients with Stage II or more severe disease were treated with gemcitabine-based adjuvant chemotherapy. The reasons for failure to receive adjuvant chemotherapy included patient refusal (n = 3), early cancer recurrence (n = 1), and malnutrition (n = 1).
Definition of morbidity and mortality
Mortality was defined as any death occurring within 90 days of surgery. Major complications were defined as having a grade of III-IV according to the Clavien classification [18] . Posthepatectomy liver failure (PHLF) was defined according to the definition of the International Study Group of Liver Surgery [19] .
Factors analyzed
The relationship of each clinical and pathological variable to postoperative morbidity and overall survival was investigated using univariable and multivariable regression analyses. The following factors were analyzed in relation to the overall morbidity after surgery: sex, age (above or below the median age), preoperative comorbidity (present vs. absent), diabetes mellitus (present vs. absent), biliary drainage (yes vs. no), preoperative cholangitis (present vs. absent), indocyanine green retention rate at 15 min (ICGR15, above or below the median value), preoperative serum bilirubin value (above or below the median value), major hepatectomy (yes vs. no), liver resection concomitant with PD (yes vs. no), liver resection concomitant with vascular resection (yes vs. no), operative time (above or below the median value), amount of bleeding (above or below the median value), intraoperative packed red blood cell transfusion (yes vs. no), and the pedicle clamping time (above or below the median value).
The following factors, classified as patient-, cancer-, or surgery-related, were analyzed in relation to overall 
Statistical analysis
Continuous data were expressed as the median (range), unless stated otherwise. Categorical and continuous data were compared between the two periods using the v 2 test and the unpaired Student t test, respectively. The median values of the continuous data were chosen as the cutoff values. A multivariable stepwise logistic regression analysis (backward elimination method) was performed to identify variables that might be significantly associated with morbidity. The overall survival rate curves were constructed using the Kaplan-Meier method, with postoperative deaths included, and univariable analyses were performed using the log rank test. A multivariable regression analysis was performed using the Cox proportional hazard model. Variables to be entered into the regression analysis were chosen based on the results of the univariable analyses (P \ 0.050). Significance was set at P \ 0.050. All the analyses were performed using PASW Statistics 18 (SPSS, Inc., Chicago, IL, USA).
Results

Patient characteristics
The patient characteristics are summarized in Table 1 . No significant differences were observed between the two periods.
Pre-and intraoperative outcomes
Details regarding the preoperative biliary drainage are summarized in Table 2 . The approaches for biliary drainage were evenly distributed between PTBD (49.2 %) and ERBD (45.8 %) during period 1, whereas the latter was the dominant approach (85.7 %) during period 2. Unilateral biliary decompression of the future remnant liver was performed in 79.7 % of the cases during period 1 and 77.8 % of the cases during period 2, with no significant difference observed between the two periods (P = 0.828). Biliary drainage-related cholangitis was observed in 23.7 % of the cases during period 1, which was similar to the percentage observed during period 2 (30.2 %, P = 0.424). Although the surgical procedures that were used were similar between the two periods, the median operative blood loss (1,020 vs. 745 mL, P = 0.003) was significantly lower in period 2 than in period 1 ( Table 1) . The number of patients requiring perioperative red blood cell transfusion (18/70 vs. 2/74; P \ 0.0001) and the amount of fresh frozen plasma that was transfused (1,280 vs. 480 mL; P \ 0.0001) were significantly reduced in period 2 (Table 1) .
Surgical radicality
The type of hepatectomy that was used and the surgical radicality were listed according to the Bismuth-Corlette classification (Table 3) . Although the R0 resection rate was comparable between the two periods in patients with Bismuth-Corlette type I-III tumors, the rate improved from 60 % during period 1 to 80.6 % during period 2 among patients with Bismuth-Corlette type IV tumors (P = 0.097) ( Table 3) . A positive proximal ductal margin was the predominant cause of the residual tumor. Postoperative outcomes
A 71-year-old male patient died on postoperative day 31 in period 1 because of cerebral infarction 21 days after a left hepatectomy; the patient had showed no signs of liver failure. In period 2, zero mortality was achieved along with a significantly reduced morbidity rate (85.9 vs. 60.8 %, P = 0.001) and a lower major complication rate (34.3 vs. 24.3 %, P = 0.189) ( Table 4) . Among patients with cholangitis related to preoperative biliary drainage, the incidence of postoperative cholangitis was 28.6 % during period 1 and 10.5 % during period 2 ( Table 2) ; these rates were comparable to those observed in patients without preoperative biliary drainage (13.3 % during period 1, P = 0.227; and 20.5 % during period 2, P = 0.480). Figure 1 shows the postoperative outcomes stratified according to cotreatment with preoperative biliary drainage and/or PVE. Although the incidence of PHLF was higher among patients with both biliary drainage and PVE than among the other patients, the maximum postoperative serum bilirubin level was comparable irrespective of the use of biliary drainage or PVE. The postoperative maximum serum bilirubin values were weakly correlated with the resection ratio, calculated using the following equation: (1 -future liver remnant volume/total liver volume) 9 100 (r 2 = 0.068, P = 0.003, Fig. 2 ). Univariable analyses identified a blood loss of more than 900 mL and an operative time of longer than 760 min as being significantly related to overall morbidity, and blood loss was selected as an independent risk factor for morbidity in a multivariable logistic regression analysis (Table 5) . Univariable analyses failed to show any risk factors for major complications. Fig. 1 Postoperative outcomes stratified according to the period of operation, preoperative biliary drainage, and PVE. The hypertrophy ratio was defined as the ratio of the future liver remnant volumes measured after and before PVE. PVE portal vein embolization, PHLF posthepatectomy liver failure Fig. 2 Correlation between the postoperative maximum serum bilirubin value (ordinate) and the resection ratio (abscissa). Resection ratio was calculated as (1 -future liver remnant volume/total liver volume) 9 100. Linear regression; maximum serum bilirubin value = 0.314 9 resection ratio ? 24.4, r 2 = 0.068, P = 0.003 Long-term outcomes
The overall survival rate was similar between the two periods (Fig. 3) . The 5-year survival rates were 32.5 % during period 1 and 34.8 % during period 2, respectively. Univariable analyses revealed the following factors to be significantly associated with poor survival: a higher AJCC T classification, a higher G grade, positive nodal involvement, microscopic lymphatic invasion, vascular invasion, perineural invasion, R1-2 resection, and packed red blood cell transfusion (Table 6) . A multivariable analysis identified positive nodal involvement and an R1-2 resection as independent prognostic factors for survival (Table 6 ). Significant differences in the overall survival were observed between patients with and those without nodal involvement ( Fig. 4a , P \ 0.0001) and between those with a positive ductal margin and those with a negative (R0) resection margin ( Fig. 4b , P = 0.003). No significant difference was observed in terms of the extent of nodal involvement (within vs. beyond the hepatoduodenal ligament, P = 0.702, Fig. 4c ). Survival among patients with a positive margin with carcinoma in situ was poorer than among those who underwent R0 resection, although the difference did not reach statistical significance (P = 0.125). Patients with a positive margin with invasive carcinoma had a significantly poorer survival outcome than those undergoing R0 resection (P = 0.006) (Fig. 4d) .
Discussion
Major liver resection for the treatment of hilar cholangiocarcinoma carries a substantial risk of mortality because the majority of patients have impaired liver function due to cholestasis [7, 10, 11] .
With the recent refinement of surgical techniques and perioperative care [20, 21] , an improvement in operative outcome has been reported. However, the mortality rate remains relatively high at around 10 %, even in recently published studies, as shown in Table 7 [22, 23] . In the present study, the mortality rate was 1.2 % during period 1, and we achieved a zero mortality rate in the most recent decade of the study, even though a major hepatectomy was performed in a high proportion of patients (90.0 % during period 1 and 97.3 % during period 2). Furthermore, it should be emphasized that the present series included patients who underwent a concomitant PD (19 % during period 1 vs. 12 % during period 2) and patients who required vascular resection (11 % during each time period). Importantly, no liver failurerelated deaths were observed during our 23 years of experience.
The role of preoperative biliary drainage in cases of hilar cholangiocarcinoma has been a matter of debate. The routine application of biliary drainage has been extensively advocated by several Japanese centers [6, 9, 20, 21, 24] based on the results of both clinical and experimental studies [25] [26] [27] [28] , whereas the Blumgart group has consistently argued against its routine application [29] based on the findings of two retrospective studies [30, 31] . Recently, a multicenter study reported that the impact of biliary drainage depends on the type of surgery performed; namely, biliary drainage was associated with a decreased mortality rate after a right hepatectomy and, surprisingly, an increased mortality rate after a left hepatectomy [23] . In the present study, the mortality rate was far lower than that in previous reports, despite our routine application of biliary drainage for obstructive jaundice. In addition, biliary drainage was not related to an increased morbidity rate when examined using univariable analysis. It should be emphasized that, to date, zero mortality rates after liver resection for hilar cholangiocarcinoma have been achieved at Japanese centers only where biliary drainage is routinely applied [21, 24, 32] .
According to the Clavien classification, the overall incidence of postoperative morbidity was extremely high during period 1 but decreased significantly to 60.8 % during period 2. Similarly, the major complication rate also decreased from 34.3 to 24.3 % for the respective periods, but this difference was not significant. These figures for period 2 were similar to those reported in previous studies [23, 33] . Farges et al. [23] conducted a multicenter study evaluating the role of biliary drainage before a hepatectomy for hilar cholangiocarcinoma and showed that the overall morbidity and severe morbidity rates, defined as Clavien grades III to IV, were 68.6 and 27.6 %, respectively. The frequency of major complications in the present study was attributed largely to our policy of performing thoracocentesis whenever possible. Indeed, among the 33 patients with grade IIIa complications, 28 (84.8 %) Fig. 3 Overall survival rates stratified according to the time period during which the patients with hilar cholangiocarcinoma were treated; P = 0.393 (log rank test) underwent a tap for pleural effusion. As described above, the overall morbidity and major complication rates have steadily decreased over the most recent decade; however, the incidence remains relatively high. Because a major hepatectomy with PD, especially for patients with impaired liver function [34] , is reportedly associated with higher mortality and morbidity rates, our improved short-term outcomes during period 2 might reflect only the lower rate of the concomitant performance of PD. Indeed, patients who underwent concomitant PD had a higher morbidity rate than those without PD in the present study, although the difference did not reach statistical significance. Thus, we cannot fully deny the influence of the lower rate of PD on postoperative morbidity.
Similarly, a hepatectomy with vascular resection and reconstruction [5, 7, [35] [36] [37] is known to influence the mortality and morbidity rates. However, because the vascular resection rate was comparable between the two periods, explaining the improvement in the short-term outcomes during period 2 based on the rate of vascular resection and reconstruction is difficult.
Because the surgical treatment of hilar cholangiocarcinoma is technically demanding and challenging [32] , the reported median blood loss is typically nearly 2 L, even in high-volume centers [32, 38] . The present study showed a marked reduction in the median blood loss from 1,020 to 745 mL by enhancing the meticulousness of the surgical procedure, namely, careful hemostasis, especially during c Survival for patients with the prognostic factor stratified further according to the extent of nodal involvement, i.e., within vs. beyond parenchymal transection; this reduction was achieved without any increase in operative time despite the use of comparable surgical procedures between the two periods. Of note, the amount of blood lost was identified by multivariable analysis as an independent risk factor of postoperative morbidity, suggesting that the reduction in blood loss contributed to the reduction in the morbidity rate during period 2. Our results were in line with those of previous studies, which showed that intraoperative blood loss [39] and subsequent blood transfusion [40] increased the risk of postoperative mortality and morbidity after liver resection. In summary, although further improvement in perioperative outcomes remains possible, surgical treatment, specifically a major hepatectomy, for hilar cholangiocarcinoma, can be safely performed using our perioperative treatment policy and meticulous surgical techniques.
While the short-term outcomes have improved steadily over the last decade, the long-term outcomes remained roughly the same between the two periods. The 5-year survival rates for each period were similar to those in previous reports, which ranged from 22 to 37 % [7, 8, 20, 22, 41, 42] .
Complete tumor clearance is known to be a significant predictor of long-term survival after surgical treatment for hilar cholangiocarcinoma. Indeed, among the several surgery-related variables that were analyzed in the present study, R0 resection was the only independent prognostic factor to be identified in multivariable analysis. The R0 resection rates in the present study were comparable to previously reported values [7, 8] . Because a positive proximal ductal margin was a predominant cause of the residual tumor in the present study, a further improvement of the R0 resection rate might be achieved by the aggressive application of a left or right trisectionectomy [43, 44] . However, since a trisectionectomy involves the removal of 65-80 % of the liver, the application of such an extensive procedure could heighten the risk of postoperative liver failure, especially in patients with cholestasis-induced impairments in liver function. Hence, the potential benefit of the procedure for obtaining a cancer-free ductal margin should be balanced against the accompanying risks.
Although a positive ductal margin has been known to have a negative impact on the long-term outcome after surgical resection of hilar cholangiocarcinoma [5, 7, 8, 20, 45] , previous reports have shown that the overall survival was comparable between patients with a negative ductal margin and those with positive margins with carcinoma in situ after surgical resection for extrahepatic cholangiocarcinoma [46] [47] [48] . In the present study, patients with a Table 7 Mortality, morbidity, and 5-year survival rates after surgical treatment of hilar cholangiocarcinoma in previous reports positive margin with carcinoma in situ had a poorer overall survival (although the difference did not reach statistical significance) than those who underwent R0 resection, showing a clear contrast to the results of previous studies. This difference can be explained by considering that the present study included only patients with hilar cholangiocarcinoma. The small number of patients with carcinoma in situ might also have affected the outcomes. Further studies are needed to confirm whether the details of a positive ductal margin status have an impact on long-term survival in patients with hilar cholangiocarcinoma.
This study had several limitations including a small sample size, retrospective design, and long study period. However, our principal treatment protocol remained the same throughout the entire study period. Despite these limitations, we believe that our results are of interest, since only a few reports published in the English-language medical literature have achieved a zero mortality rate after the surgical treatment of hilar cholangiocarcinoma.
In conclusion, while the perioperative outcomes after the surgical treatment of hilar cholangiocarcinoma have steadily improved based on the accumulation of experience and a meticulous surgical technique to reduce blood loss, the longterm outcomes remain unsatisfactory. Further improvement of the R0 resection rate could prolong patient survival.
